CryptoTradeSignals

ZILLIQA: NEW EXCHANGE LISTING 48 HOURS = 38.41% PROFIT!!!

BINANCE:ZILBTC   Zilliqa / Bitcoin
Our "Crypto Bottom" Trade Signal has correctly identified a buy in point on the 7th of May 2018.

Using this buy in point and selling at today's price, you would have expected to net 38.41% PROFIT!!! IN 48 HOURS.

The increase in price may also be explained by positive developments including:

April 1: Zilliqa Testnet v1.0 Release: Codename Red Prawn.

April 3: Zilliqa Closes In On Visa’s 8000 Transactions Per Second

April 10: Zilliqa secures a partnership with Noorcoin, a shariah compliant token. This unique market has so far identified a capacity of over 1.5 billion Muslims and is set to grow as per the market demand in crypto.

April 11: Bluezelle identifies partnerships with Zilliqa.

April 11: Zilliqa distributes Test v1.0 tokens. These tokens were used to test transactions on the test net.

April 24: GenaroNetwork GNX partners with zilliqa to improve the speed and scalability of blockchaintechnology and ecosystems.

May 1: Zilliqa announces new smart contract language called Scilla, that will allow developers to more easily develop smart contract applications that are safe, secure and scalable. Future functionality will allow anyone to be able to port their existing Solidity applications ( Ethereum) over to Scilla.

May 2: Insurance Market launches Inmediate, a new Eco-System for Blockchain Insurance, in collaboration with Zilliqa, FWD and Deloitte.

May 3: GO PAX (Korean Exchange) to lists ZILs.

May 3: ZIL gets listed on GOPAX (Korean Exchange).

May 3: Koinex (Indian Exchange) lists ZIL.

(NEW) May 8: OKex (Chinese Exchange) lists ZIL.

These factors have together with the substantial increase in trading volume (as a result of a Zilliqa's listing on Okex) have led to Zilliqa's increase in price.

GO TO: www.cryptotradesignals.org for access to ALL OUR TRADING INDICATORS + SET UP GUIDE!
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.